TransMedics Group (NASDAQ:TMDX – Get Free Report) and Adagio Medical (NASDAQ:ADGM – Get Free Report) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, profitability, valuation, dividends and institutional ownership.
Insider and Institutional Ownership
99.7% of TransMedics Group shares are owned by institutional investors. Comparatively, 48.1% of Adagio Medical shares are owned by institutional investors. 6.9% of TransMedics Group shares are owned by insiders. Comparatively, 8.9% of Adagio Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Analyst Recommendations
This is a breakdown of recent ratings for TransMedics Group and Adagio Medical, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| TransMedics Group | 0 | 7 | 5 | 0 | 2.42 |
| Adagio Medical | 1 | 1 | 2 | 0 | 2.25 |
Volatility and Risk
TransMedics Group has a beta of 2.14, meaning that its stock price is 114% more volatile than the S&P 500. Comparatively, Adagio Medical has a beta of 0.07, meaning that its stock price is 93% less volatile than the S&P 500.
Earnings & Valuation
This table compares TransMedics Group and Adagio Medical”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| TransMedics Group | $605.49 million | 4.89 | $190.29 million | $3.69 | 23.10 |
| Adagio Medical | $600,000.00 | 80.76 | -$25.08 million | ($29.75) | -0.06 |
TransMedics Group has higher revenue and earnings than Adagio Medical. Adagio Medical is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares TransMedics Group and Adagio Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| TransMedics Group | 19.85% | 13.30% | 4.93% |
| Adagio Medical | N/A | 13.92% | 2.12% |
Summary
TransMedics Group beats Adagio Medical on 10 of the 14 factors compared between the two stocks.
About TransMedics Group
TransMedics Group, Inc. is a medical technology company focused on improving organ transplantation. Its Organ Care System (OCS) is a portable platform that perfuses donor organs with warm, oxygenated blood and nutrients while they are outside the body. The company offers OCS systems for donor hearts, lungs and livers, along with related consumables and services. The company also operates the National OCS Program in the United States, an integrated offering that combines its technology with organ procurement and transportation services.
About Adagio Medical
Adagio Medical is a medical technology company developing catheter-based systems for treating cardiac arrhythmias. Its technology uses ultra-low-temperature cryoablation, which applies very cold temperatures to create lesions in heart tissue that can interrupt abnormal electrical signals. The company’s platform includes the vCLAS system, designed for ventricular arrhythmias such as ventricular tachycardia, and the iCLAS system, designed for atrial fibrillation. These systems are intended for use in catheter ablation procedures by cardiac electrophysiology teams.
Receive News & Ratings for TransMedics Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TransMedics Group and related companies with MarketBeat.com's FREE daily email newsletter.
